We use cookies for a better user experience. Read our Privacy Policy

I Agree

Smart Insulin Pens Market

Smart Insulin Pens Market (Product: Smart Insulin Pen and Adaptors for Conventional Pen; Connectivity Type: Bluetooth and USB) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Smart Insulin Pens Market Outlook 2031

  • The global smart insulin pens market was valued at US$ 31.2 Mn in 2021
  • The global market is projected to advance at a CAGR of 11.2% from 2022 to 2031
  • The global smart insulin pens market is anticipated to reach more than US$ 90.1 Mn by the end of 2031

Analysts’ Viewpoint on Smart Insulin Pens Market Scenario

Smart insulin pens are used to deliver insulin for the treatment of type 1 and type 2 diabetes. These insulin pens have additional features such as memory function, time and dose recorder, and data transfer. Rise in prevalence of the two types of diabetes in children and adults, owing to obesity and changing lifestyle & dietary habits, is a key factor expected to drive the global smart insulin pens market in the next few years. Technological advancements and integration of glucose monitoring and therapeutics for better diabetes management are likely to propel the global smart insulin pen market during the forecast period. Manufacturers of smart insulin pens are regularly launching new products to broaden their revenue streams.

Smart Insulin Pens Market

Smart Insulin Pens Market Introduction

Smart insulin pen is a reusable injector pen that can be connected to a smartphone app, which helps diabetic patients to better manage insulin administration. Most diabetic patients have difficulty calculating their insulin dosage correctly. This can lead to insulin stacking. Adding more insulin while the rest of the insulin is still active in the body from previous doses can lead to hypoglycemia. Smart insulin pen can calculate each dose based on the current blood sugar level, carbohydrate amounts, meal size, active insulin, and settings prescribed by the doctor. It can also deliver accurate half-unit doses; help prevent skipped or missed doses; keep track of the time and amount of each dose; and remind a patient when it is time for the next one. The two types of insulin pen are disposable and reusable. Disposable pens are prefilled with insulin. These can be disposed when the insulin runs out. Reusable pen allows replacement of cartridge when empty. Overall, large number of people prefer insulin pens over syringes. It is easier to carry insulin pens and prepare doses for injection.

In 2022, the American Diabetes Association (ADA) updated its diabetes guidelines. For the first time, the ADA recommended insulin pens instead of vials and syringes. Newer devices, such as smart insulin pens, are likely to play a role in better management of diabetes, which is a chronic disease. A number of technologies have become available to help diabetic patients control their insulin usage over the last decade. Smart insulin pen can help patients adjust insulin doses, monitor blood sugar, and make dosage reminders. The global smart insulin pens market analysis indicates that different smart insulin pens are available based on patient convenience.

Request a sample to get extensive insights into the Smart Insulin Pens Market

Increase in Awareness about Diabetes to Drive Global Smart Insulin Pens Market

Diabetes is a leading cause of death globally. The prevalence of diabetes is increasing in the adult and pediatric population. In November 2018, the American Diabetes Association entered into a partnership with the American Heart Association to increase awareness about cardiovascular diseases caused due to type 2 diabetes.

Diabetes is a leading cause of death in India. The Ministry of Health and Family Welfare (MoHFW) launched mDiabetes, a mobile health initiative for the prevention and care of diabetes, in collaboration with the WHO Country Office for India and other partners. The Division of Diabetes and Translation, a department of the CDC, supports activities and programs that help prevent type 2 diabetes and improve patient health outcomes. In March 2015, NHS and Public Health England launched a National NHS Diabetes Prevention Program. Prevalence of type 2 diabetes has decreased in the U.K. through this program. The National Programme for Prevention and Control of Cancers, Diabetes, Cardiovascular Diseases, and Stroke is arranged by the National Health Mission. The program aims to strengthen the infrastructure, primary healthcare system, and health prevention. Thus, increase in awareness about diabetes is likely to drive the global smart insulin pens market share during the forecast period.

Integration of Monitoring and Therapeutic Features to Propel Smart Insulin Pens Market

Smart insulin pens offer significant advantages in diabetes management. These pens carry additional features that help record the last dose of insulin. Taking insulin every day through a syringe and needle is quite difficult and stressful. Hence, patients prefer integrated technology. Usage of smartphone and the Internet for record tracking has increased due to advances in the device connectivity technology. Integrated technology helps detect the blood glucose level and calculate the insulin dose. Additionally, it provides a predetermined time interval for insulin administration. Self-collected information by a patient is transferred via smart technological tools and apps to physicians or medical professionals. For instance, InPen insulin pens are connected with smartwatches & armbands and smart apps, which help record physical activity and transfer the data to physicians.

Surge in Adoption of Connected Medical Devices to Augment Smart Insulin Pens Market

Diabetes is a disease, in which a patient’s blood glucose level increases. Type 1 is insulin-dependent diabetes, while type 2 is non-insulin-dependent. A patient suffering from diabetes finds it quite painful and stressful to self-administer doses of insulin every day. Hence, patients are looking for pain-free, safe, cost-effective, and easy-to-handle novel insulin delivery technologies.

Smart insulin pens carry several advantages over conventional delivery. They provide better flexibility regarding the daily schedule and also improve the quality of life. These insulin pens can deliver accurate dosage of insulin. The memory feature of smart insulin pen can recall the timing and amount of the previous dose. Furthermore, the portable and convenient nature of pens is a key advantage over conventional delivery. Smart insulin pens save time, as they contain a pre-set insulin level and are prefilled. Administration of insulin with pens is time-saving and is highly preferred among children and older adults. These features of smart insulin pens lead to higher patient compliance.

Technological Advancements in Smart Insulin Pens to Fuel Global Market

Emerging technologies in smart insulin pens are projected to drive the global smart insulin pens market size during the forecast period. iSenz, an adaptor for smart insulin pens, has a feature to detect the insulin level by scanning. It provides the correct angles for injections in order to optimize the injection sites for diabetes. Easylog is an adaptor for insulin pens connected via the Internet. It provides the right dosage and offers better comfort to the patient for the treatment of chronic diseases such as diabetes. InsulCheck is a cap for insulin pens that contains a sensor to track pen usage and temperature.

Rise in Prevalence of Diabetes Propelling Demand for Adaptors for Conventional Pens

In terms of product, the smart insulin pens market has been bifurcated into adaptors for conventional pens and smart insulin pens segments. The adaptors for conventional pens segment accounted for the leading share of the global market in 2021. The trend is anticipated to continue during the forecast period. Rise in prevalence of diabetes in people of all ages across the globe is projected to drive the segment during the forecast period.

Technological advancements such as memory function and accurate dosage administration are anticipated to augment the smart insulin pens segment during the forecast period.

Regional Outlook of Global Smart Insulin Pens Market

North America accounted for major share of the global market in 2021. The market in the region is driven by the presence of key players and high rate of adoption of technologies. Rise in prevalence of diabetes and new product launches and approval are likely to propel the market in North America. The market in Europe is driven by the increase in prevalence of diabetes. According to the International Diabetes Federation, around 352 million people were at risk of developing type 2 diabetes in Europe in 2017. The smart insulin pens market in Asia Pacific is projected to grow at a rapid pace during the forecast period owing to the increase in geriatric population with diabetes in the region.

Analysis of Key Players in Global Smart Insulin Pens Market

The global smart insulin pens market is highly fragmented, with the presence of a large number of players. Key players are expanding their footprint to strengthen their position in the global market. Prominent players operating in the global smart insulin pens market are Novo Nordisk A/S, Sanofi (Sanofi-Aventis US LLC), Eli Lilly and Company, Medtronic plc, Emperra GmbH, Bigfoot Biomedical, Jiangsu Deflu Medical Device Co. Ltd., Diamesco Co. Ltd., and Ypsomed Holding AG.

Request a custom report on Smart Insulin Pens Market

Key Developments in Global Smart Insulin Pens Market

  • In July 2018, Companion Medical, a provider of advanced technological products for diabetes, received approval from the Food and Drug Administration for InPen in the U.S. The product approval enabled the company to strengthen its digital diabetes products portfolio in the U.S.
  • In March 2018, Sanofi-Aventis U.S. LLC received approval from the U.S. Food and Drug Administration for Toujeo Max SoloStar. The product approval enabled the company to strengthen its product portfolio.
  • In August 2016, Emperra GmbH E-Health Technologies launched Esysta in Germany for the treatment of type 1 and type 2 diabetes. The product launch enabled the company to strengthen its diabetes management product portfolio.

Each of these players has been profiled in the smart insulin pens market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Smart Insulin Pens Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 31.2 Mn

Market Forecast Value in 2031

More than US$ 90.1 Mn

Growth Rate (2022–2031)

11.2%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Mn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, the qualitative analysis includes drivers, restraints, opportunities, key trends, and a parent industry overview.

Competition Landscape

  • Market share analysis by the company (2021)
  • Company profiles section includes an overview, product portfolio, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product
    • Smart Insulin Pens
    • Adaptors for Conventional Pens
  • Connectivity Type
    • Bluetooth
    • USB
  • Application
    • Type 1 Diabetes
    • Type 2 Diabetes
  • Distribution Channel
    • Hospital Pharmacies
    • Online Sales
    • Retail Pharmacies
    • Diabetes Clinics / Centers

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • U.K.
  • France
  • Italy
  • Germany
  • Spain
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC Countries

Companies Profiled

  • Novo Nordisk A/S
  • Sanofi (Sanofi-Aventis US LLC)
  • Eli Lilly and Company
  • Medtronic plc
  • Emperra GmbH
  • Bigfoot Biomedical
  • Jiangsu Deflu Medical Device Co. Ltd.
  • Diamesco Co. Ltd.
  • Ypsomed Holding AG

Customization Scope

Available upon request

Pricing

Available upon request

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

How big was the global smart insulin pens market in 2021?

The global smart insulin pens market was valued at US$ 31.2 Mn in 2021

How big will be the global smart insulin pens market by 2031?

The global smart insulin pens market is projected to reach more than US$ 90.1 Mn by 2031

What was the CAGR of the global smart insulin pens market from 2017 to 2021?

The global smart insulin pens market grew at a CAGR of 4.0% from 2017 to 2021

What will be the CAGR of the global smart insulin pens market during the forecast period (2022–2031)?

The global smart insulin pens market is anticipated to grow at a CAGR of 11.2% from 2022 to 2031

What was the market share of the leading segment of the global smart insulin pens market?

The smart insulin pens segment held around 55% share of the global smart insulin pens market in 2021

Who are the prominent players in the global smart insulin pens market?

Novo Nordisk A/S, Sanofi, Eli Lilly and Company, Medtronic plc, Emperra GmbH, Bigfoot Biomedical, Jiangsu Deflu Medical Device Co. Ltd., Diamesco Co. Ltd., and Ypsomed Holding AG

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Smart Insulin Pens Market

4. Market Overview

    4.1. Introduction

        4.1.1. Segment Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Smart Insulin Pens Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Technological Advancements

    5.2. Type-I Diabetes Prevalence by region/globally

    5.3. Regulatory Scenario by Region/globally

    5.4. Key Industry Events (mergers, acquisitions, partnerships, etc.)

    5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Smart Insulin Pens Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product, 2017–2031

        6.3.1. Smart Insulin Pens

        6.3.2. Adaptors for Conventional Pens

    6.4. Market Attractiveness Analysis, by Product

7. Global Smart Insulin Pens Market Analysis and Forecast, by Connectivity Type

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Connectivity Type, 2017–2031

        7.3.1. Bluetooth

        7.3.2. USB

    7.4. Market Attractiveness Analysis, by Connectivity Type

8. Global Smart Insulin Pens Market Analysis and Forecast, by Application

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Application, 2017–2031

        8.3.1. Type 1 Diabetes

        8.3.2. Type 2 Diabetes

    8.4. Market Attractiveness Analysis, by Application

9. Global Smart Insulin Pens Market Analysis and Forecast, by Distribution Channel

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Market Value Forecast, by Distribution Channel, 2017–2031

        9.3.1. Hospital Pharmacies

        9.3.2. Retail Pharmacies

        9.3.3. Diabetes Clinics/Centers

        9.3.4. E-commerce

    9.4. Market Attractiveness Analysis, by Distribution Channel

10. Global Smart Insulin Pens Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Market Value Forecast, by Region

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East & Africa

    10.3. Market Attractiveness Analysis, by Region

11. North America Smart Insulin Pens Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product, 2017–2031

        11.2.1. Smart Insulin Pens

        11.2.2. Adaptors for Conventional Pens

    11.3. Market Value Forecast, by Connectivity Type, 2017–2031

        11.3.1. Bluetooth

        11.3.2. USB

    11.4. Market Value Forecast, by Application, 2017–2031

        11.4.1. Type 1 Diabetes

        11.4.2. Type 2 Diabetes

    11.5. Market Value Forecast, by Distribution Channel, 2017–2031

        11.5.1. Hospital Pharmacies

        11.5.2. Retail Pharmacies

        11.5.3. Diabetes Clinics/Centers

        11.5.4. E-commerce

    11.6. Market Value Forecast, by Country, 2017–2031

        11.6.1. U.S.

        11.6.2. Canada

    11.7. Market Attractiveness Analysis

        11.7.1. By Product

        11.7.2. By Connectivity Type

        11.7.3. By Application

        11.7.4. By Distribution Channel

        11.7.5. By Country

12. Europe Smart Insulin Pens Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2017–2031

        12.2.1. Smart Insulin Pens

        12.2.2. Adaptors for Conventional Pens

    12.3. Market Value Forecast, by Connectivity Type, 2017–2031

        12.3.1. Bluetooth

        12.3.2. USB

    12.4. Market Value Forecast, by Application, 2017–2031

        12.4.1. Type 1 Diabetes

        12.4.2. Type 2 Diabetes

    12.5. Market Value Forecast, by Distribution Channel, 2017–2031

        12.5.1. Hospital Pharmacies

        12.5.2. Retail Pharmacies

        12.5.3. Diabetes Clinics/Centers

        12.5.4. E-commerce

    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Market Attractiveness Analysis

        12.7.1. By Product

        12.7.2. By Connectivity Type

        12.7.3. By Application

        12.7.4. By Distribution Channel

        12.7.5. By Country/Sub-region

13. Asia Pacific Smart Insulin Pens Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product, 2017–2031

        13.2.1. Smart Insulin Pens

        13.2.2. Adaptors for Conventional Pens

    13.3. Market Value Forecast, by Connectivity Type, 2017–2031

        13.3.1. Bluetooth

        13.3.2. USB

    13.4. Market Value Forecast, by Application, 2017–2031

        13.4.1. Type 1 Diabetes

        13.4.2. Type 2 Diabetes

    13.5. Market Value Forecast, by Distribution Channel, 2017–2031

        13.5.1. Hospital Pharmacies

        13.5.2. Retail Pharmacies

        13.5.3. Diabetes Clinics/Centers

        13.5.4. E-commerce

    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Market Attractiveness Analysis

        13.7.1. By Product

        13.7.2. By Connectivity Type

        13.7.3. By Application

        13.7.4. By Distribution Channel

        13.7.5. By Country/Sub-region

14. Latin America Smart Insulin Pens Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product, 2017–2031

        14.2.1. Smart Insulin Pens

        14.2.2. Adaptors for Conventional Pens

    14.3. Market Value Forecast, by Connectivity Type, 2017–2031

        14.3.1. Bluetooth

        14.3.2. USB

    14.4. Market Value Forecast, by Application, 2017–2031

        14.4.1. Type 1 Diabetes

        14.4.2. Type 2 Diabetes

    14.5. Market Value Forecast, by Distribution Channel, 2017–2031

        14.5.1. Hospital Pharmacies

        14.5.2. Retail Pharmacies

        14.5.3. Diabetes Clinics/Centers

        14.5.4. E-commerce

    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Market Attractiveness Analysis

        14.7.1. By Product

        14.7.2. By Connectivity Type

        14.7.3. By Application

        14.7.4. By Distribution Channel

        14.7.5. By Country/Sub-region

15. Middle East & Africa Smart Insulin Pens Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value Forecast, by Product, 2017–2031

        15.2.1. Smart Insulin Pens

        15.2.2. Adaptors for Conventional Pens

    15.3. Market Value Forecast, by Connectivity Type, 2017–2031

        15.3.1. Bluetooth

        15.3.2. USB

    15.4. Market Value Forecast, by Application, 2017–2031

        15.4.1. Type 1 Diabetes

        15.4.2. Type 2 Diabetes

    15.5. Market Value Forecast, by Distribution Channel, 2017–2031

        15.5.1. Hospital Pharmacies

        15.5.2. Retail Pharmacies

        15.5.3. Diabetes Clinics/Centers

        15.5.4. E-commerce

    15.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East & Africa

    15.7. Market Attractiveness Analysis

        15.7.1. By Product

        15.7.2. By Connectivity Type

        15.7.3. By Application

        15.7.4. By Distribution Channel

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player - Competition Matrix (By Tier and Size of companies)

    16.2. Market Share Analysis, by Company, 2021

    16.3. Company Profiles

        16.3.1. Novo Nordisk A/S

            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.1.2. Product Portfolio

            16.3.1.3. Financial Overview

            16.3.1.4. SWOT Analysis

            16.3.1.5. Strategic Overview

        16.3.2. Sanofi (Sanofi-Aventis US LLC)

            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.2.2. Product Portfolio

            16.3.2.3. Financial Overview

            16.3.2.4. SWOT Analysis

            16.3.2.5. Strategic Overview

        16.3.3. Eli Lilly and Company

            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.3.2. Product Portfolio

            16.3.3.3. Financial Overview

            16.3.3.4. SWOT Analysis

            16.3.3.5. Strategic Overview

        16.3.4. Medtronic plc

            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.4.2. Product Portfolio

            16.3.4.3. Financial Overview

            16.3.4.4. SWOT Analysis

            16.3.4.5. Strategic Overview

        16.3.5. Emperra GmbH

            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.5.2. Product Portfolio

            16.3.5.3. Financial Overview

            16.3.5.4. SWOT Analysis

            16.3.5.5. Strategic Overview

        16.3.6. Bigfoot Biomedical

            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.6.2. Product Portfolio

            16.3.6.3. Financial Overview

            16.3.6.4. SWOT Analysis

            16.3.6.5. Strategic Overview

        16.3.7. Jiangsu Deflu Medical Device Co. Ltd.

            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.7.2. Product Portfolio

            16.3.7.3. Financial Overview

            16.3.7.4. SWOT Analysis

            16.3.7.5. Strategic Overview

        16.3.8. Diamesco Co. Ltd.

            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.8.2. Product Portfolio

            16.3.8.3. Financial Overview

            16.3.8.4. SWOT Analysis

            16.3.8.5. Strategic Overview

        16.3.9. Ypsomed Holding AG

            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.9.2. Product Portfolio

            16.3.9.3. Financial Overview

            16.3.9.4. SWOT Analysis

            16.3.9.5. Strategic Overview

List of Tables

Table 01: Global Smart Insulin Pens Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global Smart Insulin Pens Market Value (US$ Mn) Forecast, by Connectivity Type, 2017–2031

Table 03: Global Smart Insulin Pens Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 04: Global Smart Insulin Pens Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

Table 05: Global Smart Insulin Pens Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 06: North America Smart Insulin Pens Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 07: North America Smart Insulin Pens Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 08: North America Smart Insulin Pens Market Value (US$ Mn) Forecast, by Connectivity Type, 2017–2031

Table 09: North America Smart Insulin Pens Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 10: North America Smart Insulin Pens Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

Table 12: Europe Smart Insulin Pens Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 13: Europe Smart Insulin Pens Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 14: Europe Smart Insulin Pens Market Value (US$ Mn) Forecast, by Connectivity Type, 2017–2031

Table 15: Europe Smart Insulin Pens Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 16: Europe Smart Insulin Pens Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

Table 17: Asia Pacific Smart Insulin Pens Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 18: Asia Pacific Smart Insulin Pens Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 19: Asia Pacific Smart Insulin Pens Market Value (US$ Mn) Forecast, by Connectivity Type, 2017–2031

Table 20: Asia Pacific Smart Insulin Pens Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 21: Asia Pacific Smart Insulin Pens Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

Table 22: Latin America Smart Insulin Pens Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 23: Latin America Smart Insulin Pens Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 24: Latin America Smart Insulin Pens Market Value (US$ Mn) Forecast, by Connectivity Type, 2017–2031

Table 25: Latin America Smart Insulin Pens Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 26: Latin America Smart Insulin Pens Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

Table 27: Middle East & Africa Smart Insulin Pens Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 28: Middle East & Africa Smart Insulin Pens Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 29: Middle East & Africa Smart Insulin Pens Market Value (US$ Mn) Forecast, by Connectivity, Type 2017–2031

Table 30: Middle East & Africa Smart Insulin Pens Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 31: Middle East & Africa Smart Insulin Pens Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

List of Figures

Figure 01: Global Smart Insulin Pens Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Smart Insulin Pens Market Value Share, by Product, 2021

Figure 03: Global Smart Insulin Pens Market Value Share, by Connectivity Type, 2021

Figure 04: Global Smart Insulin Pens Market Value Share, by Application, 2021

Figure 05: Global Smart Insulin Pens Market Value Share, by Distribution Channel, 2021

Figure 06: Global Smart Insulin Pens Market, by Product, 2021 and 2031

Figure 07: Global Smart Insulin Pens Market Attractiveness Analysis, by Smart Insulin Pen, 2021–2031

Figure 08: Global Smart Insulin Pens Market Attractiveness Analysis, by Adaptors for Conventional Pens, 2021–2031

Figure 09: Global Smart Insulin Pens Market, by Connectivity Type, 2021 and 2031

Figure 10: Global Smart Insulin Pens Market Attractiveness Analysis, by Connectivity Type, 2021–2031

Figure 11: Global Smart Insulin Pens Market Attractiveness Analysis, by Bluetooth, 2021–2031

Figure 12: Global Smart Insulin Pens Market Attractiveness Analysis, by USB, 2021–2031

Figure 13: Global Smart Insulin Pens Market, by Application, 2021 and 2031

Figure 14: Global Smart Insulin Pens Market Attractiveness Analysis, by Application, 2021–2031

Figure 15: Global Smart Insulin Pens Market (US$ Mn), by Type 1 Diabetes, 2017–2031

Figure 16: Global Smart Insulin Pens Market (US$ Mn), by Type 2 Diabetes, 2017–2031

Figure 17: Global Smart Insulin Pens Market, by Distribution Channel, 2021 and 2031

Figure 18: Global Smart Insulin Pens Market Attractiveness Analysis, by Distribution Channel, 2021–2031

Figure 19: Global Smart Insulin Pens Market (US$ Mn), by Hospital Pharmacies, 2017–2031

Figure 20: Global Smart Insulin Pens Market (US$ Mn), by Online Sales, 2017–2031

Figure 21: Global Smart Insulin Pens Market (US$ Mn), by Retail Pharmacies, 2017–2031

Figure 22: Global Smart Insulin Pens Market (US$ Mn), by Diabetes Clinics/Centers, 2017–2031

Figure 23: Global Smart Insulin Pens Market Value Share Analysis, by Region, 2021 and 2031

Figure 24: Global Smart Insulin Pens Market Attractiveness Analysis, by Region, 2017–2031

Figure 25: North America Smart Insulin Pens Market Value (US$ Mn) Forecast, 2017–2031

Figure 26: North America Smart Insulin Pens Market Value Share Analysis, by Country, 2021 and 2031

Figure 27: North America Smart Insulin Pens Market Attractiveness Analysis, by Country, 2021–2031

Figure 28: North America Smart Insulin Pens Market Value Share Analysis, by Product, 2021 and 2031

Figure 29: North America Smart Insulin Pens Market Attractiveness Analysis, by Product, 2021–2031

Figure 30: North America Smart Insulin Pens Market Value Share Analysis, by Connectivity Type, 2021 and 2031

Figure 31: North America Smart Insulin Pens Market Attractiveness Analysis, by Connectivity Type, 2021–2031

Figure 32: North America Smart Insulin Pens Market Value Share Analysis, by Application, 2021 and 2031

Figure 33: North America Smart Insulin Pens Market Attractiveness Analysis, by Application, 2021–2031

Figure 34: North America Smart Insulin Pens Market Value Share Analysis, by Distribution Channel, 2021 and 2031

Figure 35: North America Smart Insulin Pens Market Attractiveness Analysis, by Distribution Channel, 2021–2031

Figure 36: Europe Smart Insulin Pens Market Value (US$ Mn) Forecast, 2017–2031

Figure 37: Europe Smart Insulin Pens Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 38: Europe Smart Insulin Pens Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 39: Europe Smart Insulin Pens Market Value Share Analysis, by Product, 2021 and 2031

Figure 40: Europe Smart Insulin Pens Market Attractiveness Analysis, by Product, 2021–2031

Figure 41: Europe Smart Insulin Pens Market Value Share Analysis, by Connectivity Type, 2021 and 2031

Figure 42: Europe Smart Insulin Pens Market Attractiveness Analysis, by Connectivity Type, 2021–2031

Figure 43: Europe Smart Insulin Pens Market Value Share Analysis, by Application, 2021 and 2031

Figure 44: Europe Smart Insulin Pens Market Attractiveness Analysis, by Application, 2021–2031

Figure 45: Europe Smart Insulin Pens Market Value Share Analysis, by Distribution Channel, 2021 and 2031

Figure 46: Europe Smart Insulin Pens Market Attractiveness Analysis, by Distribution Channel, 2021–2031

Figure 47: Asia Pacific Smart Insulin Pens Market Value (US$ Mn) Forecast, 2017–2031

Figure 48: Asia Pacific Smart Insulin Pens Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 49: Asia Pacific Smart Insulin Pens Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 50: Asia Pacific Smart Insulin Pens Market Value Share Analysis, by Product, 2021 and 2031

Figure 51: Asia Pacific Smart Insulin Pens Market Attractiveness Analysis, by Product, 2021–2031

Figure 52: Asia Pacific Smart Insulin Pens Market Value Share Analysis, by Connectivity Type, 2021 and 2031

Figure 53: Asia Pacific Smart Insulin Pens Market Attractiveness Analysis, by Connectivity Type, 2021–2031

Figure 54: Asia Pacific Smart Insulin Pens Market Value Share Analysis, by Application, 2021 and 2031

Figure 55: Asia Pacific Smart Insulin Pens Market Attractiveness Analysis, by Application, 2021–2031

Figure 56: Asia Pacific Smart Insulin Pens Market Value Share Analysis, by Distribution Channel, 2021 and 2031

Figure 57: Asia Pacific Smart Insulin Pens Market Attractiveness Analysis, by Distribution Channel, 2021–2031

Figure 58: Latin America Smart Insulin Pens Market Value (US$ Mn) Forecast, 2017–2031

Figure 59: Latin America Smart Insulin Pens Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 60: Latin America Smart Insulin Pens Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 61: Latin America Smart Insulin Pens Market Value Share Analysis, by Product, 2021 and 2031

Figure 62: Latin America Smart Insulin Pens Market Attractiveness Analysis, by Product, 2021–2031

Figure 63: Latin America Smart Insulin Pens Market Value Share Analysis, by Connectivity Type, 2021 and 2031

Figure 64: Latin America Smart Insulin Pens Market Attractiveness Analysis, by Connectivity Type, 2021–2031

Figure 65: Latin America Smart Insulin Pens Market Value Share Analysis, by Application, 2021 and 2031

Figure 66: Latin America Smart Insulin Pens Market Attractiveness Analysis, by Application, 2021–2031

Figure 67: Latin America Smart Insulin Pens Market Value Share Analysis, by Distribution Channel, 2021 and 2031

Figure 68: Latin America Smart Insulin Pens Market Attractiveness Analysis, by Distribution Channel, 2021–2031

Figure 69: Middle East & Africa Smart Insulin Pens Market Value (US$ Mn) Forecast, 2017–2031

Figure 70: Middle East & Africa Smart Insulin Pens Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 71: Middle East & Africa Smart Insulin Pens Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 72: Middle East & Africa Smart Insulin Pens Market Value Share Analysis, by Product, 2021 and 2031

Figure 73: Middle East & Africa Smart Insulin Pens Market Attractiveness Analysis, by Product, 2021–2031

Figure 74: Middle East & Africa Smart Insulin Pens Market Value Share Analysis, by Connectivity Type, 2021 and 2031

Figure 75: Middle East & Africa Smart Insulin Pens Market Attractiveness Analysis, by Connectivity Type, 2021–2031

Figure 76: Middle East & Africa Smart Insulin Pens Market Value Share Analysis, by Application, 2021 and 2031

Figure 77: Middle East & Africa Smart Insulin Pens Market Attractiveness Analysis, by Application, 2021–2031

Figure 78: Middle East & Africa Smart Insulin Pens Market Value Share Analysis, by Distribution Channel, 2021 and 2031

Figure 79: Middle East & Africa Smart Insulin Pens Market Attractiveness Analysis, by Distribution Channel, 2021–2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

126

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved